British Columbia Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,396
Closed -$1.78M 710
2025
Q1
$1.78M Buy
30,396
+7
+0% +$474 0.01% 642
2024
Q4
$2.19M Buy
30,389
+4,082
+16% +$300K 0.01% 608
2024
Q3
$2.1M Sell
26,307
-3,815
-13% -$287K 0.01% 604
2024
Q2
$2.16M Buy
30,122
+11,371
+61% +$837K 0.01% 596
2024
Q1
$1.32M Buy
18,751
+544
+3% +$38.9K 0.01% 667
2023
Q4
$1.4M Buy
18,207
+4,029
+28% +$265K 0.01% 628
2023
Q3
$965K Hold
14,178
0.01% 649
2023
Q2
$1.16M Buy
14,178
+360
+3% +$28.9K 0.01% 605
2023
Q1
$1.03M Hold
13,818
0.01% 643
2022
Q4
$1.15M Sell
13,818
-1,606
-10% -$128K 0.01% 590
2022
Q3
$1.09M Sell
15,424
-2,752
-15% -$238K 0.01% 621
2022
Q2
$1.57M Sell
18,176
-6,088
-25% -$571K 0.01% 583
2022
Q1
$2.63M Sell
24,264
-3,148
-11% -$325K 0.02% 575
2021
Q4
$3.54M Sell
27,412
-1,400
-5% -$172K 0.02% 535
2021
Q3
$3.49M Sell
28,812
-168
-0.6% -$20.4K 0.02% 546
2021
Q2
$3.26M Buy
+28,980
New +$3.05M 0.02% 580
2015
Q1
Sell
-26,492
Closed -$612K 772
2014
Q4
$612K Hold
26,492
0.01% 667
2014
Q3
$620K Hold
26,492
0.01% 653
2014
Q2
$613K Hold
26,492
0.01% 659
2014
Q1
$565K Hold
26,492
﹤0.01% 663
2013
Q4
$627K Buy
26,492
+1,796
+7% +$38.9K 0.01% 654
2013
Q3
$494K Buy
24,696
+1,340
+6% +$25.4K ﹤0.01% 670
2013
Q2
$403K Buy
+23,356
New +$388K ﹤0.01% 688

Other funds holding TECH

British Columbia Investment Management's TECH Position: Q2 2025 in Review

British Columbia Investment Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 30,396 shares — an estimated $1.78M sold.

British Columbia Investment Management first reported a position in TECH in Q2 2013 and held it in 23 quarters. The position peaked at $3.54M in Q4 2021. 555 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • British Columbia Investment Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • British Columbia Investment Management sold 30,396 Bio-Techne shares in Q2 2025, an estimated $1.78M.
  • British Columbia Investment Management first reported a position in Bio-Techne in Q2 2013 and held it in 23 quarters.
  • British Columbia Investment Management's Bio-Techne position peaked at $3.54M in Q4 2021.
  • 555 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on British Columbia Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.